is diarrhea a side effect of glp 1 Managing GLP-1/GIP effects with diet and lifestyle GLP-1 Medications: Understanding How to
Description
Gaudelli, N.M
(2025, February 1)
In Phase 1 and 2a clinical trials, once-daily subcutaneous injections of RG7697 (0.252.5 mg) for 14 days in 56 patients with T2DM and 1.8 mg of RG7697 for 12 weeks in patients with T2DM who were poorly responsive to metformin reduced body weight and improved glycemic control
Upon reinitiation, liraglutide injection should be titrated at the discretion of the healthcare provider
In conclusion, these advances in GLP-1RA-based nanoplatforms underscore the transformative potential of integrating nanotechnology with metabolic therapeutics for more effective obesity management
In July 2023, she began taking Mounjaro instead of Ozempic
